Article
Molecular basis of rifampin resistance in Mycobacterium leprae.
Antimicrobial agents and chemotherapy - 1 Mar 1993
Honore N, Cole S T
Abstract excerpt
Rifampin is currently the most potent drug used in leprosy control programs. We show that the rifampin resistance which emerged in nine patients with lepromatous leprosy, who had received rifampin monotherapy, stemmed from mutations in the rpoB gene, which encodes the beta subunit of RNA polymerase of Mycobacterium leprae. In eight cases missense mutations were found to affect a serine residue, Ser-425, while in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
